✦ LIBER ✦

Current Status and Perspectives of Tyrosine Kinase Inhibitor Treatment in the Posttransplant Period in Patients with Chronic Myelogenous Leukemia (CML)

✍ Scribed by Evgeny Klyuchnikov; Nicolaus Kröger; Tim H. Brummendorf; Bettina Wiedemann; Axel Rolf Zander; Ulrike Bacher

Book ID: 116281154
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 171 KB
Volume: 16
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2009.08.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular diagnosis and monitoring in th

Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors

✍ Joyce Ou; Jo-Anne Vergilio; Adam Bagg 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

## Abstract The well‐established molecular pathogenesis of chronic myelogenous leukemia (CML) and its consequences for laboratory testing and clinical management illustrate a classic paradigm for the importance of molecular diagnostics in targeted drug therapy. The success of the tyrosine kinase in

Occurrence and current management of sid

Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with tyrosine kinase inhibitors

✍ Breccia, Massimo; Alimena, Giuliana 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Has the time for first-line treatment wi

Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis

✍ Gurion, R.; Gafter-Gvili, A.; Vidal, L.; Leader, A.; Ram, R.; Shacham-Abulafia, 📂 Article 📅 2012 🏛 Ferrata Storti Foundation 🌐 Italian ⚖ 915 KB

Nonadherence And Treatment Interruption

Nonadherence And Treatment Interruption Of Tyrosine Kinase Inhibitors Association With Health Care Resource Cost And Utilization In Chronic Myeloid Leukemia Patients

✍ Hsieh, K.P.; Chen, L.C.; Lin, C.L.; Yang, Y.H. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

The effect of interleukin 11 on thromboc

The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

✍ Ahmed Aribi; Hagop Kantarjian; Charles Koller; Deborah Thomas; Stefan Faderl; Gu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

Prior treatment with the tyrosine kinase

Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemia

✍ Shimoni, A; Leiba, M; Schleuning, M; Martineau, G; Renaud, M; Koren-Michowitz, M 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB